Geode Capital Management’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Buy |
138,982
+1,972
| +1% | +$17.9K | ﹤0.01% | 3262 |
|
|
2025
Q1 | $1.31M | Buy |
137,010
+2,939
| +2% | +$28K | ﹤0.01% | 3210 |
|
|
2024
Q4 | $1.51M | Buy |
134,071
+521
| +0.4% | +$5.85K | ﹤0.01% | 3226 |
|
|
2024
Q3 | $1.92M | Buy |
133,550
+5,861
| +5% | +$84.2K | ﹤0.01% | 3143 |
|
|
2024
Q2 | $2.2M | Buy |
127,689
+69,445
| +119% | +$1.2M | ﹤0.01% | 3102 |
|
|
2024
Q1 | $1.16M | Buy |
58,244
+11,428
| +24% | +$228K | ﹤0.01% | 3312 |
|
|
2023
Q4 | $493K | Buy |
46,816
+724
| +2% | +$7.62K | ﹤0.01% | 3617 |
|
|
2023
Q3 | $408K | Buy |
46,092
+6,159
| +15% | +$54.5K | ﹤0.01% | 3679 |
|
|
2023
Q2 | $385K | Hold |
39,933
| – | – | ﹤0.01% | 3746 |
|
|
2023
Q1 | $551K | Hold |
39,933
| – | – | ﹤0.01% | 3608 |
|
|
2022
Q4 | $606K | Sell |
39,933
-2,326
| -6% | -$35.3K | ﹤0.01% | 3576 |
|
|
2022
Q3 | $384K | Buy |
42,259
+1,280
| +3% | +$11.6K | ﹤0.01% | 3869 |
|
|
2022
Q2 | $347K | Sell |
40,979
-28,733
| -41% | -$243K | ﹤0.01% | 3958 |
|
|
2022
Q1 | $1.37M | Buy |
69,712
+2,292
| +3% | +$44.9K | ﹤0.01% | 3465 |
|
|
2021
Q4 | $1.64M | Buy |
67,420
+10,501
| +18% | +$255K | ﹤0.01% | 3474 |
|
|
2021
Q3 | $2.22M | Buy |
56,919
+4,524
| +9% | +$177K | ﹤0.01% | 3298 |
|
|
2021
Q2 | $2.35M | Buy |
52,395
+37,932
| +262% | +$1.7M | ﹤0.01% | 3215 |
|
|
2021
Q1 | $493K | Buy |
14,463
+7,443
| +106% | +$254K | ﹤0.01% | 3815 |
|
|
2020
Q4 | $256K | Buy |
+7,020
| New | +$256K | ﹤0.01% | 3810 |
|